Literature DB >> 27270761

Carotid Artery Stenting With Proximal Embolic Protection via a Transradial or Transbrachial Approach: Pushing the Boundaries of the Technique While Maintaining Safety and Efficacy.

Piero Montorsi1, Stefano Galli2, Paolo M Ravagnani2, Simone Tresoldi3, Giovanni Teruzzi2, Luigi Caputi4, Daniela Trabattoni2, Franco Fabbiocchi2, Giuseppe Calligaris2, Luca Grancini2, Alessandro Lualdi2, Stefano de Martini2, Antonio L Bartorelli2.   

Abstract

PURPOSE: To compare the feasibility and safety of proximal cerebral protection to a distal filter during carotid artery stenting (CAS) via a transbrachial (TB) or transradial (TR) approach.
METHODS: Among 856 patients who underwent CAS between January 2007 and July 2015, 214 (25%) patients (mean age 72±8 years; 154 men) had the procedure via a TR (n=154) or TB (n=60) approach with either Mo.MA proximal protection (n=61) or distal filter protection (n=153). The Mo.MA group (mean age 73±7 years; 54 men) had significantly more men and more severe stenosis than the filter group (mean age 71±8 years; 100 men). Stent type and CAS technique were left to operator discretion. Heparin and a dedicated closure device or bivalirudin and manual compression were used in TR and TB accesses, respectively. Technical and procedure success, crossover to femoral artery, 30-day major adverse cardiovascular/cerebrovascular events (MACCE; death, all strokes, and myocardial infarction), vascular complications, and radiation exposure were compared between groups.
RESULTS: Crossover to a femoral approach was required in 1/61 (1.6%) Mo.MA patient vs 11/153 (7.1%) filter patients mainly due to technical difficulty in engaging the target vessel. Five Mo.MA patients developed acute intolerance to proximal occlusion; 4 were successfully shifted to filter protection. A TR patient was shifted to filter because the Mo.MA system was too short. CAS was technically successful in the remaining 55 (90%) Mo.MA patients and 142 (93%) filter patients. The MACCE rate was 0% in the Mo.MA patients and 2.8% in the filter group (p=0.18). Radiation exposure was similar between groups. Major vascular complications occurred in 1/61 (1.6%) and in 3/153 (1.96%) patients in the Mo.MA and filter groups (p=0.18), respectively, and were confined to the TB approach in the early part of the learning curve. Chronic radial artery occlusion was detected by Doppler ultrasound in 2/30 (6.6%) Mo.MA patients and in 4/124 (3.2%) filter patients by clinical assessment (p=0.25) at 8.1±7.5-month follow-up.
CONCLUSION: CAS with proximal protection via a TR or TB approach is a feasible, safe, and effective technique with a low rate of vascular complications.
© The Author(s) 2016.

Entities:  

Keywords:  brachial artery access; carotid artery stent; cerebral protection; embolic protection; filter; proximal embolic protection; radial artery access

Mesh:

Substances:

Year:  2016        PMID: 27270761     DOI: 10.1177/1526602816651424

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  4 in total

1.  Carotid artery stenting with proximal embolic protection via the transbrachial approach: sheathless navigation of a 9-F balloon-guiding catheter.

Authors:  Junpei Koge; Tomonori Iwata; Tetsuya Hashimoto; Shigehisa Mizuta; Yukihiko Nakamura; Eri Tanaka; Masakazu Kawajiri; Shun-Ichi Matsumoto; Takeshi Yamada
Journal:  Neuroradiology       Date:  2018-08-22       Impact factor: 2.804

Review 2.  Carotid Angioplasty and Stenting and Embolic Protection.

Authors:  Enrico Giordan; Giuseppe Lanzino
Journal:  Curr Cardiol Rep       Date:  2017-10-18       Impact factor: 2.931

3.  Transcervical access via direct neck exposure for neurointerventional procedures in the hybrid angiosuite.

Authors:  Jong Young Lee; Jong-Hwa Park; Hong Jun Jeon; Dae Young Yoon; Seoung Woo Park; Byung Moon Cho
Journal:  Neuroradiology       Date:  2018-03-01       Impact factor: 2.804

Review 4.  Transcervical access, reversal of flow and mesh-covered stents: New options in the armamentarium of carotid artery stenting.

Authors:  Kosmas I Paraskevas; Frank J Veith
Journal:  World J Cardiol       Date:  2017-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.